AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $701,835 | +4.5% | 10,042 | +7.5% | 0.00% | +100.0% |
Q2 2023 | $671,316 | +15.5% | 9,342 | -0.8% | 0.00% | 0.0% |
Q1 2023 | $581,149 | -20.0% | 9,422 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $726,719 | +51.1% | 9,422 | -12.5% | 0.00% | +100.0% |
Q3 2022 | $481,000 | -3.4% | 10,772 | -17.1% | 0.00% | 0.0% |
Q2 2022 | $498,000 | -25.3% | 12,992 | -19.4% | 0.00% | 0.0% |
Q1 2022 | $667,000 | +9.5% | 16,122 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $609,000 | +10.3% | 16,122 | -3.8% | 0.00% | 0.0% |
Q3 2021 | $552,000 | -51.2% | 16,760 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $1,131,000 | +73.7% | 16,760 | +45.8% | 0.00% | +100.0% |
Q1 2021 | $651,000 | -28.4% | 11,497 | +3.0% | 0.00% | -50.0% |
Q4 2020 | $909,000 | +1.8% | 11,157 | -10.9% | 0.00% | 0.0% |
Q3 2020 | $893,000 | -3.9% | 12,527 | +11.0% | 0.00% | 0.0% |
Q2 2020 | $929,000 | +44.0% | 11,287 | +3.0% | 0.00% | 0.0% |
Q1 2020 | $645,000 | -37.3% | 10,960 | +10.0% | 0.00% | -33.3% |
Q4 2019 | $1,029,000 | +320.0% | 9,960 | +4.5% | 0.00% | +200.0% |
Q2 2019 | $245,000 | – | 9,530 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |